Related Experiment Video
Updated: Aug 16, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury
Michiyo Kaneko1, Loredana Bucciarelli, Yuying C Hwang
1Division of Surgical Science, P&S 17-401, Columbia University Medical Center, 630 West 168th St., New York, NY 10032, USA.
Insights
Diabetes impairs heart function by increasing glucose metabolism through the polyol pathway, specifically aldose reductase. This leads to reduced glycolysis and worsened cardiac outcomes during ischemia in diabetic patients.
Area of Science:
- Cardiology
- Diabetology
- Biochemistry
Background:
- Cardiovascular disease is a leading cause of death in diabetes mellitus patients.
- Diabetic cardiomyopathy and increased myocardial sensitivity to ischemia are significant complications.
- The polyol pathway's role in diabetic cardiac complications is under investigation.
Purpose of the Study:
- To investigate the role of the polyol pathway, particularly aldose reductase, in diabetic myocardial dysfunction.
- To examine the impact of advanced glycation end products (AGEs) on myocardial ischemic injury in diabetes.
Main Methods:
- Demonstration of increased glucose flux via aldose reductase in diabetic myocardium.
- Assessment of glycolysis under normoxic and ischemic conditions.
- Investigation of AGEs and receptor for AGEs (RAGE) interactions.
Main Results:
- Diabetes increases glucose flux through aldose reductase in the myocardium.
- This increased flux impairs glycolysis in diabetic hearts, both in normal and ischemic conditions.
- Elevated AGEs and RAGE interactions contribute to cardiac dysfunction.
Conclusions:
- The polyol pathway, via aldose reductase, plays a critical role in diabetic heart disease.
- Increased aldose reductase activity and AGEs/RAGE signaling contribute to cardiac dysfunction in diabetes.
- Targeting the polyol pathway may offer therapeutic potential for diabetic cardiovascular complications.
Abstract:
Cardiovascular disease represents the major cause of morbidity and mortality in patients with diabetes mellitus. The impact of cardiac disease includes increased sensitivity of diabetic myocardium to ischemic episodes and diabetic cardiomyopathy, manifested as a subnormal functional response of the diabetic heart independent of coronary artery disease. In this context, we were to our knowledge the first to demonstrate that diabetes increases glucose flux via the first and key enzyme, aldose reductase, of the polyol pathway, resulting in impaired glycolysis under normoxic and ischemic conditions in diabetic myocardium. Our laboratory has been investigating the role of the polyol pathway in mediating myocardial ischemic injury in diabetics. Furthermore, the influence of the aldose reductase pathway in facilitating generation of key potent glycating compounds has led us to investigate the impact of advanced glycation end products (AGEs) in myocardial ischemic injury in diabetics. The potent impact of increased flux via the aldose reductase pathway and the increased AGE interactions with its receptor (RAGE) resulting in cardiac dysfunction will be discussed in this chapter.
Related Concept Videos
Phase I Reactions: Reductive Reactions
Redox Reactions
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Ischemic Stroke ll: Pathophysiology
